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Background Acne vulgaris is a common condition that occurs in all skin types. Postinflammatory hyperpigmentation (PIH) is often associated with acne in patients of
darker skin types, making it a common complaint in dermatology offices. Despite
this, there is limited understanding of and effective treatment options for PIH.
Objectives The study objective was to validate an in vivo model for PIH and to compare the clinical, histological and spectroscopic characteristics of artificially
induced PIH and acne-induced PIH.
Methods A nonblinded, nonrandomized pilot study was performed. Thirty subjects
served as their own control in which four sites treated with 35% trichloroacetic
acid (TCA) solution and four truncal acne pustules were followed for 8 weeks and
were evaluated clinically and histologically, and by colorimetry and spectroscopy.
Results The initial phases of inflammation between TCA- and acne-induced PIH
differ. However, clinical evaluations were similar on and after day 14. Acne- and
TCA-induced lesions were clinically, histologically and spectroscopically indistinguishable at day 28.
Conclusions Clinical, spectroscopic and histological similarities of acne-induced and
TCA-induced PIH at day 28 suggest that TCA-induced PIH can be a reproducible
model for the study of acne-induced PIH.

What’s already known about this topic?

•
•

What does this study add?

•
•

862

Postinflammatory hyperpigmentation (PIH) is skin discoloration due to multiple
insults and more frequently affects darker-skinned patients.
However, we don’t know if different causes of PIH have similar clinical and spectroscopic properties.

A model to induce PIH has been introduced.
It possesses similar clinical, spectroscopic and histological properties as acneinduced PIH. This model will allow us to design future structured mechanistic
studies to help manage PIH.
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Postinflammatory hyperpigmentation (PIH) is an acquired
hypermelanosis. This process can occur in all skin types but
more frequently affects darker-skinned patients.1 PIH can occur
after an infection, contact dermatitis, drug reaction, burns, surgical or cosmetic procedures, or any other cutaneous inflammatory insult.1–4 In people of colour, PIH frequently occurs in
resolving acne lesions and can persist for months after the acne
lesion itself has disappeared.5 In many cases, the resulting PIH
can be more distressing than the original inflammatory insult.6
The pathogenesis of PIH includes an increase in melanin production and/or an abnormal distribution of this melanin.7
This pilot study was designed to test the hypothesis that
PIH caused by iatrogenically induced injury would follow a
similar process as acne-induced PIH, hence potentially serving
as a model to study the latter. The acute phase of these two
inflammatory models would necessarily differ. There are challenges in developing these protocols because there is no
validated measure to quantify changes in individual lesions of
PIH. Thus, the project focused on comparing the Investigator’s Global Assessment (IGA) scale, histology and
spectroscopy.

Materials and methods
Patient selection
The Institutional Review Board of Henry Ford Hospital
approved this study (IRB #7013). All guidelines from the
Declaration of Helsinki were followed. Written informed consent was obtained from all patients. Subjects who were
18 years or older were eligible if they had existing truncal
acne with at least four clinically apparent pustules in coexistence with PIH or postinflammatory erythema which were
secondary to truncal acne as confirmed by IGA.
Study design
The study was a nonblinded, nonrandomized study. Subjects
were recruited at the Department of Dermatology of Henry
Ford Hospital, Detroit, Michigan. In subjects meeting the enrolment criteria, four PIH lesions were induced on the right buttock with a 35% trichloroacetic acid (TCA) solution placed
onto the skin using a thin cotton swab for 30 s or until the skin
showed signs of frosting. The size of each of the four TCAinduced PIH lesions was approximately 050 cm2. Both truncal
acne pustules and induced TCA lesions were monitored using
diffuse reflectance spectroscopy (DRS), colorimetry, clinical
photographs and IGA on days 0, 1, 7, 14, 28, 42 and 56.

looks at the contrast between diseased and normal skin. The
contrast is what we believe most affects a subject’s quality of
life and self-esteem and not the overall degree of pigmentation. An IGA of zero corresponds to a subject’s normal skin at
baseline, and subsequent IGA scores are relative to that
baseline. Normalizing against a subject’s baseline helps to
eliminate any effect of skin phototype on pigmentation
assessment.
Colorimetric and spectroscopic measurements
Skin pigmentation was objectively measured with colorimetry,
hyperspectral imaging (HSI) and DRS. The colorimeter consisted of a spectrophotometer (Konica Minolta CM-2600d,
Osaka, Japan) that used a xenon arc lamp and a computer.
The HSI system consisted of a uniform illumination source,
Lowel Vip Pro-light halogen tungsten lamp (Lowel-Light Manufacturing, Inc., Hauppauge, NY, U.S.A.) and Lite panel LED
panels, a hyperspectral camera with sensor Philumina-VNIR/
400H (PhiLumina, LLC, Gulfport, MS, U.S.A.) capable of
detecting absorbance in the wavelength range of 400–
1000 nm, and a computer. The components of the DRS were
the light source (HL-2000 Ocean Optics deuterium tungsten
halogen lamp), a broadband spectrophotometer (USB 2000
light detector, BWTEK Inc., Newark, DE, U.S.A.) that was capable of detecting absorbance in the wavelength range 350–
850 nm, a 25-mm bifurcated fibre-optic probe that was
applied to the subject’s skin, and a computer. The reflectance
spectrometer unit emits visible light onto the skin and then
analyses the collected light that is reflected from the skin.
Histological evaluation
TCA was applied on day 0. At day 1, subjects underwent a 4mm punch biopsy of a representative truncal acne lesion, and
Table 1 Investigator’s Global Assessment (IGA) description of
hyperpigmentation and erythema
IGA scale

Hyperpigmentation

Erythema

0

Clear of
hyperpigmentation
Almost clear of
hyperpigmentation
Mild, but noticeable
hyperpigmentation
Moderate
hyperpigmentation
(medium brown in quality)
Severe hyperpigmentation
(dark brown in quality)

Clear of erythema

1
2
3

4

Assessments
5

Clinical global assessment
A six-point IGA scale for hyperpigmentation and erythema
(Table 1) was developed by investigators of this study at the
Department of Dermatology, Henry Ford Hospital. The scale
© 2015 British Association of Dermatologists

Very severe
hyperpigmentation
(very dark brown,
almost black in quality)

Almost clear
of erythema
Mild, but noticeable
erythema
Moderate erythema
(pink in quality)
Severe erythema
(dark pink in
quality)
Very severe
erythema
(very dark pink,
almost red in
quality)
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of one of the TCA-induced lesions. A second set of biopsies
were done of a TCA-induced PIH lesion and of an acneinduced PIH lesion on day 28. Therefore, a total of five skin
biopsies were obtained: two from acne lesions (days 1 and
28), two from TCA-induced lesions (days 1 and 28), and one
from normal uninvolved skin for the same patient at the end
of the study. Samples were stained with haematoxylin and
eosin and Melan-A.
Statistical analysis
Statistical analysis was performed to compare the IGA scores of
both types of lesions. Comparisons were made of the number
of melanocytes and melanophages between normal skin and
acne-induced PIH and between normal skin and TCA-induced
PIH. Acne-induced PIH and TCA-induced PIH melanocyte and
melanophage counts were also compared. Melanin content
measured by HSI was compared between normal skin and
acne-induced PIH, normal skin and TCA-induced PIH, as well
as between acne-induced PIH and TCA-induced PIH. Comparisons were made using a two-tailed paired-sample t-test. In
cases where distributional normality was significantly violated,
the nonparametric Wilcoxon signed-rank test was used instead
due to the paired nature of the data. Statistical significance was
set at P < 005, and all analyses were done using SAS software
(version 92, SAS Institute Inc., Cary, NC, U.S.A.).

Results
Study population
Thirty subjects were enrolled and all completed the study. The
final data analysis for IGA was done on all 30 subjects. The
mean age was 326 years (range 18–63). Two subjects were
of Fitzpatrick skin type II, five subjects were of skin type IV,
19 subjects were of skin type V, and four subjects were of
skin type VI.
Clinical global assessment
Photographs of acne and TCA can be seen in Figures 1 and 2,
respectively. IGA scores for hyperpigmentation and erythema
(a)

(b)

over time are shown in Figure 3. In Figure 3a, the high TCA
hyperpigmentation IGA, seen on day 1, was a false positive as
it was due to necrosis secondary to frosting from the TCA. In
day 28 there is a downward trend and subsequent plateauing
of the TCA hyperpigmentation IGA, which reflects true hyperpigmentation. In contrast, acne hyperpigmentation trends
upward then plateaus at day 28 and then is found to have a
similar course as the TCA hyperpigmentation. In Figure 3b,
the initial peak in the IGA erythema score for the TCA was
also a false positive, secondary to initial inflammatory
response to TCA application.
The IGA scores for the acne-induced PIH and TCA-induced
PIH were statistically significantly different on days 0, 1 and 7
(P < 005). However, there were no statistically significant
differences in the IGA scores for the two lesions on days 14,
28, 42 and 56 (P > 005). Subsequently, the average IGA
scores for both acne-induced PIH and TCA-induced PIH were
indistinguishable at week 2 and reached a plateau at day 28
with average scores of 29 and 30, respectively. Over time,
IGA scores for acne- and TCA-induced postinflammatory erythema have the same course.
Colorimetric and spectroscopic measurements
Colorimetry and DRS measurements were obtained for all sites
for every subject. The data on day 28 were selected for statistical analyses for both these instruments as the IGA scores for
acne and TCA were similar at this time point. Colorimetry
measurements are expressed as L* (lightness to darkness), a*
(green to red) and b* (blue to yellow) colour parameters.
DRS measurements are used to determine relative melanin,
oxyhaemoglobin and deoxyhaemoglobin content. DRS has
been shown to be a good assessment tool for melanin.8 Therefore, only melanin content was considered for the DRS data
analysis. Average acne measurements were determined for
each patient per visit. The data was normalized based on their
average acne value of that visit. A common statistical method
known as discriminant function analysis was used to analyse
the spectroscopic measurements.9 The discriminant function
analysis method classifies the data into the independent groups
(acne or TCA) by minimizing the variations within the groups
and maximizing variations between the groups. The compar(c)

Fig 1. Acne lesion: Investigator’s Global Assessment. (a) Day 1: erythema, 4; hyperpigmentation, 0. (b) Day 28: erythema, 3; hyperpigmentation,
2. (c) Day 56: erythema, 0; hyperpigmentation, 3.
British Journal of Dermatology (2016) 174, pp862–868
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(a)

(b)

(c)

Fig 2. Trichloroacetic acid lesion: Investigator’s Global Assessment. (a) Day 1: erythema, 0. (b) Day 28: erythema, 2; hyperpigmentation, 4. (c)
Day 56: erythema, 2; hyperpigmentation, 4.

Fig 3. (a) Means and standard errors for IGA
scores for hyperpigmentation over time. (b)
Means and standard errors for IGA scores for
erythema over time. Ery, erythema; IGA,
Investigator’s Global Assessment; PIH,
postinflammatory hyperpigmentation; TCA,
trichloroacetic acid.

ison between the two groups (acne and TCA) resulted in only
one discriminant function.
The plots of discriminant function against each category for
both the colorimetry and DRS data can be seen in Figure 4.
Each symbol in the plot represents a single optical measurement. The discriminant scores (y-axis) of acne and TCA are
very similar and they highly overlap with each other. A leaveone-out cross-validation classification also was performed
using their discriminant scores.10 In this method, each data
point is treated as an unknown case and is tested against all
the other data points. The classification results were used to
determine the sensitivity and specificity of the data. In our
analysis, sensitivity [= TP/(TP + FN)] and specificity [= TN/
(TN + FP)] were derived based on the following interpretation: true positives (TP) indicate a TCA-induced PIH lesion
was correctly identified as a TCA-induced lesion. True negatives (TN) indicate an acne-induced PIH measurement was
correctly classified as acne. False positives (FP) indicate an
acne-induced PIH measurement was incorrectly classified as a
TCA-induced lesion. False negatives (FN) indicate a TCAinduced lesion measurement was incorrectly classified as acne.
In other words, the sensitivity is defined as the ratio of true
TCA identification over all the TCA data points, and the specificity is determined by true acne identification over the total
acne data points. The results showed that the sensitivity of
TCA was 51% in colorimetry and 553% in DRS. The specificities are 775% and 638% for colorimetry and DRS, respectively. The sensitivity towards TCA was further reduced to
467% and 538% for colorimetry and DRS, respectively,
© 2015 British Association of Dermatologists

when each patient was considered as a test case (one patient
at a time) while the rest of the data set was treated as the
training set. Specificity values showed no discernible differences (colorimetry 776% and DRS 633%). The results
demonstrate that colorimetry and DRS do not distinguish
between TCA-induced PIH and acne-induced PIH and indicate
that both share similar optical characteristics.
HSI was done for all sites for 12 subjects on their day 28
visit. HSI measurements were used to determine melanin concentration11,12 and data was normalized against adjacent normal skin. Table 2 shows the measured melanin content in
acne-induced PIH and TCA-induced PIH along with that in
adjacent normal skin. There was a statistically significant difference (P < 005) between melanin content in acne-induced
PIH and adjacent normal skin as well as in TCA-induced PIH
and adjacent normal skin on day 28. However, there was no
statistically significant difference between melanin content in
acne-induced PIH and TCA-induced PIH on day 28, indicating
the similarity in the optical characteristics exhibited by both
lesions. HSI results are consistent with colorimetry and DRS
findings.
Histological evaluation
Skin biopsies of normal uninvolved skin, acne-induced PIH
and TCA-induced PIH taken on day 28 were analysed. On day
1, acne pustules were characterized by perifollicular neutrophilic inflammation, whereas TCA lesions had full-thickness
epidermal necrosis with perivascular and/or perifollicular lymBritish Journal of Dermatology (2016) 174, pp862–868
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Fig 4. Left: discriminant function plot for
colorimetry. Right: discriminant function plot
for diffuse reflectance spectroscopy. TCA,
trichloroacetic acid.

phocytic inflammation. Skin biopsies obtained on day 1 were
excluded during analysis as the majority of TCA samples were
found to have evidence of full-thickness epidermal necrosis,
thus making it difficult to compare with the acne samples
from day 1.
By day 28, both acne-induced PIH and TCA-induced PIH
showed perifollicular and perivascular lymphocytic inflammation and dermal fibrosis. Melanophage density was determined
by counting the melanophages per 4 high-power fields, while
the melanocyte count was done by counting the melanocytes
per 05 mm of the epidermis. All counts were done, in a
blinded fashion, by the same dermatopathologist (M.C.). A
comparison of melanophages and melanocytes was performed
for normal skin, acne-induced PIH and TCA-induced PIH on
day 28, and there were no statistically significant differences
from normal skin. Table 3 contains the comparison of melanocytes and melanophages at day 28 between acne-induced
PIH and TCA-induced PIH, and is also shown in Figure 5. The
mean and median melanocyte number was slightly higher in

Table 2 Melanin content measured in acne-induced PIH and TCAinduced PIH and adjacent normal skin from hyperspectral imaging for
12 patients
Average
acne
melanin

Average control
melanin for
acne site (back)

Average
TCA
melanin

Average control
melanin for TCA
site (buttock)

0056467
0215752
0043785
0107896
0101724
0322422
0123757
0309831
0154633
0113893
0115667
0229533

0025585803
0164950029
004100552
0062999554
0057498571
0205447582
0087189432
0256709902
0112066221
0063197817
0089087433
0184161474

00436
02340
01225
01738
01080
02504
02448
03038
03082
01664
01633
02383

002723
018096
008526
013790
006651
025449
018445
026917
025804
014521
009928
021827

PIH, postinflammatory hyperpigmentation; TCA, trichloroacetic
acid.
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the TCA-induced PIH samples, but the difference is not statistically significant. For melanophages, the mean is higher for
the acne-induced PIH samples, but the difference is also not
statistically significant.

Discussion
To our knowledge, this is the first study to create and validate
an in vivo model for PIH. In this study, PIH was induced using
35% TCA. This medium-depth chemical peel can cause
damage to the epidermis and papillary dermis, thus producing
epidermal necrosis, papillary dermal oedema and homogenization, and a sparse lymphocytic infiltrate within the first couple
of days.13 These effects were seen histologically when the TCA
lesions were biopsied on day 1 (24 h after TCA application).
Because necrosis was the cause of the initial apparent discoloration that was seen in the TCA lesions, they were not given
a day 1 IGA score as this was not true hyperpigmentation.
Within 7–14 days after applying the TCA, the necrotic crust
peeled away and hyperpigmentation subsequently developed,
allowing for the IGA scoring to take place on subsequent visits. The IGA for TCA and acne erythema were noted to
decrease with time. The IGA for TCA-induced PIH data is also
consistent with general clinical observations about acneinduced PIH, in that resolution takes weeks to months.1,5
Spectroscopy is a noninvasive method routinely used to
objectively evaluate pigmentary disorders.14,15 The spectroscopic data (colorimetry, DRS and HSI) obtained in this study
demonstrate that PIH induced from acne and TCA share similar optical characteristics, validating this as a model to study
PIH. Melanin is essential for skin pigmentation.16,17 The histology results in this study indicated that there was no statistically significant difference in the mean number of counted
melanocytes and melanophages in the acne-induced PIH and
TCA-induced PIH lesions. Also, no statistically significant difference in the mean number of counted melanocytes and melanophages was reported between acne-induced PIH and
normal skin or TCA-induced PIH and normal skin. Because the
IGA scores were relative to normal skin and were supported
by spectroscopic measurements, it appears that spectroscopy
and IGA scores allow for better distinction of PIH from nor© 2015 British Association of Dermatologists
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Table 3 Melanocytes and melanophages at day 28 from histology
n
Melanocytes
Acne
24
TCA
24
Melanophages
Acne
29
TCA
29

Mean (SD)

Median (Min, Max)

P-value

88 (57)
103 (57)

8 (0, 21)
10 (2, 21)

0408

66 (48)
64 (47)

5 (0, 15)
5 (0, 16)

0994

MAX, maximum; Min, minimum; TCA, trichloroacetic acid.

mal skin. This supports the fact that spectroscopy and IGA can
more effectively distinguish PIH from normal skin than
haematoxylin and eosin staining. Additionally, the differences
in cellular infiltrate did not appear to distinguish TCA-induced
PIH from acne-induced PIH.
Our study was limited by a small sample size and a discrepancy in the number of skin biopsies analysed as some patients
refused skin biopsies of normal skin as well as day 28 biopsies. Another limitation was the use of a relatively high concentration of TCA. Although we used 35% TCA, commonly
used in a medium-depth chemical peel, patients developed
significant necrosis within the first few days, thus making it
difficult to assign IGA scores during the initial visits. But, in
using 35% TCA we did get consistent pigmentation in darker
skin types with slight crusting that results in pigmentation of
a similar character to acne-induced pigmentation. Our next
study, to evaluate the use of lower TCA concentrations that

would induce PIH, should help to look into the development
of pigmentation from subnecrotic challenges.
HSI was performed on only 12 subjects due to limited
availability of instrumentation and staff. Our final limitation
was the use of our nonvalidated IGA scoring system to evaluate the hyperpigmentation and erythema. After the completion
of our study, a validated scoring system to measure PIH from
acne vulgaris, called the postacne hyperpigmentation index
(PAHPI), was reported.18 The use of the PAHPI in future studies would allow for a more standardized outcome measure as
well as assessment of the effectiveness of PIH treatments.
This study did show that spectroscopy and IGA are able to
quantify the degree of pigmentation. This further confirms
what has been found in previous PIH and melasma studies,
where histology was found to be ineffective, but spectroscopy
was effective in quantifying pigmented skin from normal
skin.19,20 Thus, the correlation between clinical and spectroscopic evaluation suggests that these two components can be
part of future clinical research to assess the efficacy of various
interventions done to treat or prevent PIH.
In summary, PIH, which commonly occurs in patients with
Fitzpatrick skin type II and above, can lead to psychological
stress and negatively impact the quality of life. Currently,
there are no uniformly effective treatments for PIH. The
results of this pilot study suggest that TCA-induced PIH could
be a reproducible model for acne-induced PIH. This initial
model for PIH using TCA serves as a foundation for us to
better understand as well as improve our ability to manage
PIH.

(a)

(b)

(c)

(d)

Fig 5. Histological changes at day 28. (a)
Acne-induced PIH; (b) TCA-induced PIH.
Haematoxylin and eosin, original
magnification 9400; arrows pointing at
melanophages. (c) Acne-induced PIH; (d)
TCA-induced PIH. Melan A stained 9400.
PIH, postinflammatory hyperpigmentation;
TCA, trichloroacetic acid.
© 2015 British Association of Dermatologists
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